South San Francisco / HER2-positive / Buffalo / Camerino / IFN / Turin / Milan / Chieti / FVB / San Jose / Santa Cruz / Minneapolis / Valencia / Como / Cambridge / Los Angeles / Bologna / Kawasaki / San Diego / /
Company
Leica Microsystems / Sigma-Aldrich / Genentech / QIAGEN / Bio-Rad Laboratories / Perez SA / IgG / Nikon Europe / Charles River Laboratories / BioMed Central Ltd. / Creative Commons / /
Country
Japan / United Kingdom / Italy / United States / / /
Facility
Alma Mater Studiorum University of Bologna / University of Turin / Horizontal bar / University of Camerino / University of Bologna / University of California / University of Bologna Ricerca Fondamentale Orientata / G D’Annunzio University / Laboratory of Immunology / Laboratory of Experimental Oncology / Rizzoli Orthopedic Institute / Central Institute / /
IndustryTerm
breast cancer therapy / Treatment of syn-HER2 cancer / cancer prevention / model systems / /
MedicalCondition
huHER2-overexpressing human cancer / ovarian cancer / mammary cancer / aggressive breast cancers / significantly decreased tumor / human tumor / ductal carcinoma / intraperitoneal tumor / maximal tumor / human tumors / human HER2-positive tumor / syn-HER2 tumor / p53/neu-driven cancer syndrome / syn-HER2 and xeno-HER2 cancer / autochthonous mammary tumors / huHER2driven carcinogenesis / human HER2-positive cancer / breast cancer / Syn-HER2 cancer / mouse mammary tumor virus / tumor / cancer / tumors / mouse tumors / human cancer / transgenic mammary carcinoma / huHER2-positive cancer / populations infiltrating tumors / metastases / mammary carcinogenesis / rhabdomyosarcoma / gastric cancer / significantly delayed tumor / preventive cancer / spontaneous mammary adenocarcinomas / dissected tumor / human cancers / lymphocyte/tumor / carcinoma / autochthonous tumor / control group tumors / ovarian carcinoma / mammary carcinoma / HER2-driven mammary carcinogenesis / minimal residual disease / disease / murine HER2-positive mammary carcinoma / mammary tumors / rat neu-driven carcinogenesis / tumour / spontaneous mammary tumors / peritoneal carcinomatosis / allogeneic tumor / midlife mammary tumors / female murine mammary tumor / multifocal mammary carcinomas / multifocal carcinogenesis / human HER2-positive cancers / huHER2-driven mammary tumors / mammary tumor / /
MedicalTreatment
breast cancer therapy / vaccination / Immunotherapy / immunization / Adoptive transfer / rehydration / vaccinations / /
NaturalFeature
Whole-mount / /
OperatingSystem
XP / /
Organization
University of California / Institutional Review Board / University of Bologna Ricerca Fondamentale Orientata / University of Bologna / Laboratory of Experimental Oncology / D’Annunzio University / Molecular Biotechnology Center / University of Camerino / Laboratory of Immunology and Biology of Metastasis / Department of Experimental Pathology / Rizzoli Orthopedic Institute / Italian Foundation for Cancer Research / Italian Association for Cancer Research / Colombo MP / Department of Experimental / Diagnostic and Specialty Medicine / Alma Mater Studiorum University of Bologna / Interdepartmental Centre for Cancer Research / University of Turin / i.p. administration / CESI Aging Research Center / Italian Ministry / Department of Surgery / Central Institute for Experimental Models / /
De Giovanni et al. Breast Cancer Research 2014, 16:R10 http://breast-cancer-research.com/content/16/1/R10